Search miRCancer Database

Search by miRNA name:      Or     And       cancer name:        

Example: mir-145, hsa-mir-21, let-7			 Example: breast cancer, lung

Search result for miRNA = 'hsa-mir-221' Or cancer = '' Total: 95 relations found.

mirId Family/Cluster Cancer Profile PubMed Article
hsa-mir-221 anaplastic thyroid carcinoma up A 4-MicroRNA signature can discriminate primary lymphomas from anaplastic carcinomas in thyroid cytology smears.
hsa-mir-221 bladder cancer up Micro-RNA profiling in kidney and bladder cancers.
hsa-mir-221 bladder cancer up MicroRNA-221 silencing predisposed human bladder cancer cells to undergo apoptosis induced by TRAIL.
hsa-mir-221 brain cancer up MicroRNA-target cross-talks: Key players in glioblastoma multiforme.
hsa-mir-221 breast cancer up TRPS1 targeting by miR-221/222 promotes the epithelial-to-mesenchymal transition in breast cancer.
hsa-mir-221 breast cancer down Knockdown of miR-221 promotes the cisplatin-inducing apoptosis by targeting the BIM-Bax/Bak axis in breast cancer.
hsa-mir-221 breast cancer up MiR-221/222 promote epithelial-mesenchymal transition by targeting Notch3 in breast cancer cell lines.
hsa-mir-221 breast cancer up Slug-upregulated miR-221 promotes breast cancer progression through suppressing E-cadherin expression.
hsa-mir-221 breast cancer up From microRNA functions to microRNA therapeutics: Novel targets and novel drugs in breast cancer research and treatment (Review).
hsa-mir-221 breast cancer up Study of microRNAs-21/221 as potential breast cancer biomarkers in Egyptian women.
hsa-mir-221 breast cancer up miR-221/222 promote tumor growth and suppress apoptosis by targeting lncRNA GAS5 in breast cancer.
hsa-mir-221 breast cancer up miR-221/222 promotes S-phase entry and cellular migration in control of basal-like breast cancer.
hsa-mir-221 cervical cancer up MicroRNA-221 targets PTEN to reduce the sensitivity of cervical cancer cells to gefitinib through the PI3K/Akt signaling pathway.
hsa-mir-221 colon carcinoma up [MicroRNA-221 promotes colon carcinoma cell proliferation in vitro by inhibiting CDKN1C/p57 expression].
hsa-mir-221 colorectal cancer up MicroRNA-221 inhibits CDKN1C/p57 expression in human colorectal carcinoma.
hsa-mir-221 colorectal cancer up miR-221 inhibits autophagy and targets TP53INP1 in colorectal cancer cells.
hsa-mir-221 colorectal cancer up [MicroRNA-221 controls CDKN1C/P57 expression in human colorectal carcinoma].
hsa-mir-221 colorectal cancer up MicroRNA-221 promotes colorectal cancer cell invasion and metastasis by targeting RECK.
hsa-mir-221 esophageal cancer up Alteration of miRNA Expression Correlates with Lifestyle, Social and Environmental Determinants in Esophageal Carcinoma.
hsa-mir-221 extrahepatic cholangiocarcinoma up miR-221 Promotes Epithelial-Mesenchymal Transition through Targeting PTEN and Forms a Positive Feedback Loop with ?-catenin/c-Jun Signaling Pathway in Extra-Hepatic Cholangiocarcinoma.
hsa-mir-221 follicular thyroid carcinoma up Differential miRNA expression defines migration and reduced apoptosis in follicular thyroid carcinomas.
hsa-mir-221 gastric cancer up Deregulated microRNAs in gastric cancer tissue-derived mesenchymal stem cells: novel biomarkers and a mechanism for gastric cancer.
hsa-mir-221 gastric cancer up Increased Expression of MicroRNA-221 in gastric cancer and its clinical significance.
hsa-mir-221 gastric cancer up miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-221 gastric cancer up miR-221 and miR-222 synergistically regulate hepatocyte growth factor activator inhibitor type 1 to promote cell proliferation and migration in gastric cancer.
hsa-mir-221 gastrointestinal stromal tumor down Multiple sporadic gastrointestinal stromal tumors concomitant with ampullary adenocarcinoma: a case report with KIT and PDGFRA mutational analysis and miR-221/222 expression profile.
hsa-mir-221 gastrointestinal stromal tumor down Down-regulation of miR-221 and miR-222 correlates with pronounced Kit expression in gastrointestinal stromal tumors.
hsa-mir-221 glioblastoma up Serum expression level of miR-504 can differentiate between glioblastoma multiforme and solitary brain metastasis of non-small cell lung carcinoma.
hsa-mir-221 glioma up Uptake by human glioma cell lines and biological effects of a peptide-nucleic acids targeting miR-221.
hsa-mir-221 glioma up Co-suppression of miR-221/222 cluster suppresses human glioma cell growth by targeting p27kip1 in vitro and in vivo.
hsa-mir-221 glioma up MicroRNA-221 targeting PI3-K/Akt signaling axis induces cell proliferation and BCNU resistance in human glioblastoma.
hsa-mir-221 glioma up MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma.
hsa-mir-221 glioma up MiR-221/222 promote human glioma cell invasion and angiogenesis by targeting TIMP2.
hsa-mir-221 glioma down Suppression of miR-221 inhibits glioma cells proliferation and invasion via targeting SEMA3B.
hsa-mir-221 hepatocellular carcinoma up miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation.
hsa-mir-221 hepatocellular carcinoma up MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma.
hsa-mir-221 hepatocellular carcinoma up Differentially Expressed miRNAs in Hepatocellular Carcinoma Target Genes in the Genetic Information Processing and Metabolism Pathways.
hsa-mir-221 hepatocellular carcinoma up Clinical potential of miRNA-221 as a novel prognostic biomarker for hepatocellular carcinoma.
hsa-mir-221 hepatocellular carcinoma up MiR-221 mediates the epithelial-mesenchymal transition of hepatocellular carcinoma by targeting AdipoR1.
hsa-mir-221 hepatocellular carcinoma up Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice.
hsa-mir-221 hepatocellular carcinoma up miR-221 regulates CD44 in hepatocellular carcinoma through the PI3K-AKT-mTOR pathway.
hsa-mir-221 hepatocellular carcinoma up miR-221 suppression through nanoparticle-based miRNA delivery system for hepatocellular carcinoma therapy and its diagnosis as a potential biomarker.
hsa-mir-221 hepatocellular carcinoma up In vivo and in vitro effects of microRNA-221 on hepatocellular carcinoma development and progression through the JAK-STAT3 signaling pathway by targeting SOCS3.
hsa-mir-221 hepatocellular carcinoma up Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its progno
hsa-mir-221 hepatocellular carcinoma up MicroRNAs in Hepatobiliary and Pancreatic Cancers.
hsa-mir-221 hepatocellular carcinoma up Increased MiR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro.
hsa-mir-221 hepatocellular carcinoma up Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma.
hsa-mir-221 laryngeal squamous cell carcinoma up Up-regulated miR-221 expression as a molecular diagnostic marker in laryngeal squamous cell carcinoma and its correlation with Apaf-1 expression.
hsa-mir-221 liver cancer up Expression and prognostic significance of miR-375 and miR-221 in liver cancer.
hsa-mir-221 liver cancer up Bioinformatics analysis identifies miR-221 as a core regulator in hepatocellular carcinoma and its silencing suppresses tumor properties.
hsa-mir-221 malignant melanoma up The abrogation of the HOXB7/PBX2 complex induces apoptosis in melanoma through the miR-221&222-c-FOS pathway.
hsa-mir-221 medulloblastoma down Identification of microRNA signature in different pediatric brain tumors.
hsa-mir-221 neuroblastoma up microRNA-221 enhances MYCN via targeting nemo-like kinase, and functions as an oncogene related to poor prognosis in neuroblastoma.
hsa-mir-221 non-small cell lung cancer up miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation.
hsa-mir-221 non-small cell lung cancer up miRNA-221 acts as an oncogenic role by directly targeting TIMP2 in non-small-cell lung carcinoma.
hsa-mir-221 non-small cell lung cancer up Overexpression of MicroRNA-221 is associated with poor prognosis in non-small cell lung cancer patients.
hsa-mir-221 non-small cell lung cancer up Serum expression level of miR-504 can differentiate between glioblastoma multiforme and solitary brain metastasis of non-small cell lung carcinoma.
hsa-mir-221 non-small cell lung cancer up MicroRNA-221 promotes human non-small cell lung cancer cell H460 growth.
hsa-mir-221 non-small cell lung cancer down Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer.
hsa-mir-221 oral squamous cell carcinoma up miR-221 and miR-222 expression increased the growth and tumorigenesis of oral carcinoma cells.
hsa-mir-221 oral squamous cell carcinoma up Downregulation of miR-221/222 by a microRNA sponge promotes apoptosis in oral squamous cell carcinoma cells through upregulation of PTEN.
hsa-mir-221 oral squamous cell carcinoma up Downregulation of miR-221 Inhibits Cell Migration and Invasion through Targeting Methyl-CpG Binding Domain Protein 2 in Human Oral Squamous Cell Carcinoma Cells.
hsa-mir-221 osteosarcoma up Long Noncoding RNA GAS5 Suppresses Cell Growth and Epithelial-Mesenchymal Transition in Osteosarcoma by Regulating the miR-221/ARHI Pathway.
hsa-mir-221 osteosarcoma up miR-221 increases osteosarcoma�cell�proliferation, invasion and migration partly through�the downregulation of PTEN.
hsa-mir-221 osteosarcoma up MicroRNA-221 Induces Cell Survival and Cisplatin Resistance through PI3K/Akt Pathway in Human Osteosarcoma.
hsa-mir-221 ovarian cancer up Micro-RNAs and ovarian cancer: the state of art and perspectives of clinical research.
hsa-mir-221 ovarian cancer up Overexpression of miRNA-221 promotes cell proliferation by targeting the apoptotic protease activating factor-1 and indicates a poor prognosis in ovarian cancer.
hsa-mir-221 ovarian cancer up miR-221 regulates proliferation and apoptosis of ovarian cancer cells by targeting BMF.
hsa-mir-221 mir-221 pancreatic adenocarcinoma up Antisense inhibition of microRNA-21 or -221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma.
hsa-mir-221 pancreatic cancer up miR-221/222 induces pancreatic cancer progression through the regulation of matrix metalloproteinases.
hsa-mir-221 pancreatic cancer up Down-regulation of miR-221 inhibits proliferation of pancreatic cancer cells through up-regulation of PTEN, p27(kip1), p57(kip2), and PUMA.
hsa-mir-221 pancreatic cancer up Metformin Causes G1-Phase Arrest via Down-Regulation of MiR-221 and Enhances TRAIL Sensitivity through DR5 Up-Regulation in Pancreatic Cancer Cells.
hsa-mir-221 papillary thyroid carcinoma up Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients.
hsa-mir-221 papillary thyroid carcinoma up MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.
hsa-mir-221 papillary thyroid carcinoma up In vivo imaging of functional targeting of miR-221 in papillary thyroid carcinoma.
hsa-mir-221 papillary thyroid carcinoma up In vivo imaging of miR-221 biogenesis in papillary thyroid carcinoma.
hsa-mir-221 papillary thyroid carcinoma up Integrated analyses of microRNA and mRNA expression profiles in aggressive papillary thyroid carcinoma.
hsa-mir-221 papillary thyroid carcinoma up [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
hsa-mir-221 papillary thyroid carcinoma up Differential Expression of MicroRNAs in Papillary Thyroid Carcinoma and Their Role in Racial Disparity.
hsa-mir-221 prostate cancer down Downregulation of miR-221, -30d, and -15a contributes to pathogenesis of prostate cancer by targeting Bmi-1.
hsa-mir-221 prostate cancer up Effects of microRNA-221/222 on cell proliferation and apoptosis in prostate cancer cells.
hsa-mir-221 prostate cancer down MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour suppressor and disease progression marker.
hsa-mir-221 prostate cancer up The correlation between microRNA-221/222 cluster overexpression and malignancy: an updated meta-analysis including 2693 patients.
hsa-mir-221 prostate cancer up MiR-221 promotes the development of androgen independence in prostate cancer cells via downregulation of HECTD2 and RAB1A.
hsa-mir-221 rectal cancer up Expression of Circulating miR-155, miR-21, miR-221, miR-30a, miR-34a and miR-29a: Comparison of Colonic and Rectal Cancer.
hsa-mir-221 renal cell carcinoma up miRNA-221 promotes proliferation, migration and invasion by targeting TIMP2 in renal cell carcinoma.
hsa-mir-221 retinoblastoma up Upregulated miR-221/222 promotes cell proliferation and invasion and is associated with invasive features in retinoblastoma.
hsa-mir-221 squamous carcinoma up Unique MicroRNA Expression Profiles in Cervical Cancer.
hsa-mir-221 thyroid carcinoma up MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle.
hsa-mir-221* gastric cancer up MicroRNA profiling of human gastric cancer.
hsa-mir-221-3p cervical cancer up MicroRNA-221-3p, a TWIST2 target, promotes cervical cancer metastasis by directly targeting THBS2.
hsa-mir-221-3p hepatocellular carcinoma up Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
hsa-mir-221-3p hepatocellular carcinoma up MicroRNA deregulation in nonalcoholic steatohepatitis-associated liver carcinogenesis.
hsa-mir-221-3p medulloblastoma down Downregulation of EIF5A2 by miR-221-3p inhibits cell proliferation, promotes cell cycle arrest and apoptosis in medulloblastoma cells.
hsa-mir-221-3p pancreatic cancer up MicroRNA-221-3p is up-regulated and serves as a potential biomarker in pancreatic cancer.